期刊文献+

血清CA125与子宫腺肌病相关性的分析与探讨 被引量:7

Analysis and Discussion the Correlation of Serum CA125 and Adenomyosis
下载PDF
导出
摘要 目的:本研究旨在探讨150例子宫腺肌病患者血清CA125表达水平与子宫大小、痛经的相关性,为提高子宫腺肌病的临床诊断提供依据。方法:本研究归纳统计了2009.1~2012.3于本院妇科门诊就诊150例子宫腺肌病患者血清CA125的表达水平,探讨其与子宫大小、痛经程度的相关性,应用SPSS统计软件进行统计分析。结果:150例子宫腺肌病患者中144例有痛经症状,继发性痛经116例,其中98例呈逐渐加重的趋势,患者血清CA125的阳性表达率为60%(90例),血清CA125表达水平与子宫腺肌病患者子宫大小(n=150,r=0.343,P<0.01)、痛经程度(n=150,r=0.457,P<0.01)呈正相关。结论:本研究显示血清CA125表达水平与子宫大小、痛经程度具有一定的相关性,在临床上子宫腺肌病辅助诊断及病情监测中有重要应用价值。 Objective :This study aimed to investigate 150 cases of adenomyosis patients clinical data characteristics, and explore the correlation of serum CA125 expression levels and uterine size, dysmenorrheal. Methods:The study summarized the statistics of 150 patients with adenomyosis from January 2009 to March 2012 in our gynecological clinic. Detected the expression of serum CA125 in adenomyosis, explore the correlation with uterine size and dysmenorrheal. SPSS statistical software for Statistical analysis. Results :In 150 adeuomyosis patients, 144 cases with dysmenorrhea, 116 cases with secondary dysmenorrhea, of which 98 cases were gradually aggravated, the positive expression rate of serum CA125 in patients is 60% (90cases) ,serum CA125 expres- sion level in adenomyosis patients was positive corelation with uterine size (n = 150, r = 0. 343, P 〈 0.01 ) , and the degree of dysmenorrhea( n = 150 ,r = 0. 457 ,P 〈 0. 01 ) . Conclusion:Expression of serum CA125 has a positive correlation with the size of the uterus and dysmenorrheal in adenomyosis. Serum CA125 have important application value on adenomyosis diagnosis and monitoring in clinical.
出处 《辽宁中医杂志》 CAS 2012年第12期2347-2349,共3页 Liaoning Journal of Traditional Chinese Medicine
基金 上海市科委资助课题(10DZ1974600) 上海市教委资助项目(09JW37)
关键词 子宫腺肌病 血清CA125 痛经 adenomyosis serum CA125 dysmenorrhea
  • 相关文献

参考文献7

二级参考文献28

共引文献101

同被引文献74

  • 1赵璇,邓琦,秦海燕,王萍华,沈文君.Ca125及CRP对子宫腺肌病及子宫肌瘤的诊断价值分析[J].医学信息(医学与计算机应用),2014,0(25):136-136. 被引量:2
  • 2熊开琴,张秀辉,江贤萍,韩新华,李俸媛.雌、孕激素受体和p53在胆囊癌中的表达及其临床意义[J].华西医学,2006,21(3):512-514. 被引量:2
  • 3曲银娥,王毅峰,杨梅.MMP-9基因多态性与子宫内膜异位症和子宫腺肌病关系的研究[J].中国煤炭工业医学杂志,2007,10(9):1079-1080. 被引量:1
  • 4王丹霞.子宫腺肌病与子宫肌瘤临床症状分析[J].临床误诊误治,2007,20(8):33-33. 被引量:5
  • 5国家中医药管理局.中药新药临床研究指导原则[S].北京:中国医药科技出版社,2002:29.
  • 6Kitawaki J.Adenomyosis:the pathophysiology of an oestrogen-dependent disease[J].Best Pract Res Clin Obstet Gynaecol,2006,20 (4):493-502.
  • 7Tagashira Y, Shimada M, Kigawa T. Ovarian endometrioid adenocarcinoma arising from endometriosis in a young woman. Gynecol Oncol, 2003, 91: 643-647.
  • 8Liu X, Yuan L, Guo SW. Valpmic acid as a therapy for adenomyo- sis: a comparative case series. Reprod Sci, 2010, 17:904 - 912.
  • 9Kitawaki J, Noguchi T, Amatsu T, et al. Expression of aro- matase cytochrome P450 protein andmessenger ribonucleic acid in human endometriotic and adenomyotic tissue but not in normal endometrium. Boil Reprod, 1997, 57: 514-519.
  • 10Sokalska A, Anderson M, Villanueva J, et al. Effects of simvastatin on retinoic acid system in primary human endom- etrial stromal cells and in a chimeric model of human endome- triosis. J Clin Endocrinol Metab, 2013 98: E463- 471.

引证文献7

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部